EUVIMEDEUVIMED entdecken
Crossref

How I treat newly diagnosed and refractory T-cell acute lymphoblastic lymphoma in children and young adults

Stephanie J Si Lim iD, James B Ford iD, Michelle L Hermiston iD

Blood · 2023

DOI: 10.1182/blood.2022016503 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood, 2023. Verfasst von Stephanie J Si Lim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Hawai'i, Honolulu, HI. Hauptthemen laut MEDLINE: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia-Lymphoma, Adult T-Cell. Die Arbeit wurde bisher 12-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

T-cell lymphoblastic lymphoma (T-LLy) and T-cell acute lymphoblastic leukemia (T-ALL) have historically been considered a spectrum of the same disease. However, recent evidence demonstrating differential responses to chemotherapy raise the possibility that T-LLy and T-ALL are distinct clinical and biologic entities. Here, we examine differences between the two diseases and use illustrative cases to highlight key recommendations on how to best treat newly diagnosed and relapsed/refractory T-LLy patients. We discuss results of recent clinical trials incorporating use of nelarabine and bortezomib, choice of induction steroid, role of cranial radiotherapy, and risk stratification markers to identify patients at highest risk of relapse and to further refine current treatment strategies. Because prognosis for relapsed or refractory T-LLy patients is poor, we discuss ongoing investigations incorporating novel therapies, including immunotherapeutics, into upfront and salvage regimens and the role of hematopoietic stem cell transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precursor T-Cell Lymphoblastic Leukemia-LymphomaPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia-Lymphoma, Adult T-CellHumansChildYoung AdultRecurrenceT-Lymphocytes

Autor:innen und Institutionen

  • Department of Pediatrics, University of Hawai'i, Honolulu, HI.
  • Department of Pediatrics, University of Nebraska Medical Center, Omaha, NE.
  • Department of Pediatrics, University of California San Francisco, San Francisco, CA.

ORCID-Profile: Stephanie J Si Lim, James B Ford, Michelle L Hermiston

Zitieren

APA

Si Lim, S. J., Ford, J. B., & Hermiston, M. L. (2023). How I treat newly diagnosed and refractory T-cell acute lymphoblastic lymphoma in children and young adults. Blood. https://doi.org/10.1182/blood.2022016503

Vancouver

Si Lim SJ, Ford JB, Hermiston ML. How I treat newly diagnosed and refractory T-cell acute lymphoblastic lymphoma in children and young adults. Blood. 2023. doi:10.1182/blood.2022016503

BibTeX
@article{SiLim2023,
  author = {Si Lim, Stephanie J and Ford, James B and Hermiston, Michelle L},
  title = {How I treat newly diagnosed and refractory T-cell acute lymphoblastic lymphoma in children and young adults},
  journal = {Blood},
  year = {2023},
  doi = {10.1182/blood.2022016503}
}
Kostenlos starten →